Semiglutide Brands & Alternatives Compared

Semiglutide Brands: The Complete Breakdown

Three brand-name semaglutide medications exist, all manufactured by Novo Nordisk, all containing the same active molecule. The difference comes down to FDA-approved use, dose strength, and how you take it.

Wegovy® (semaglutide injection — for weight loss)

FDA-approved in 2021 specifically for chronic weight management. Dosed weekly via subcutaneous injection, titrated from 0.25 mg up to 2.4 mg over 16 weeks. In trials, average weight loss was 15-17% of body weight at 68 weeks. Retail: $1,300-$1,600/month. The "headline" semaglutide for weight loss patients.

Ozempic® (semaglutide injection — for type 2 diabetes)

FDA-approved in 2017 for blood sugar management in type 2 diabetes. Same molecule as Wegovy, but the maximum dose tops out at 2.0 mg/week. Patients on Ozempic also experience weight loss as a "side benefit" — which is how the off-label weight loss boom started. Retail: $900-$1,000/month.

Rybelsus® (oral semaglutide pill)

The oral form, taken daily on an empty stomach. FDA-approved for type 2 diabetes only. Doses: 3, 7, or 14 mg/day. Weight loss is real but more modest — typically 6-8% body weight loss. Best for needle-averse patients who prioritize convenience over maximum results. Retail: $900-$1,000/month.

Compounded semaglutide (telehealth)

Prepared by licensed compounding pharmacies under prescription. Same active ingredient. Not FDA-approved (compounded medications are individually prepared, not mass-manufactured). Available primarily through telehealth platforms. Cost: $200-$400/month all-in. The cash-pay choice for most patients without insurance coverage.

Semiglutide vs Tirzepatide (Mounjaro/Zepbound)

Tirzepatide is the newer competitor — a "dual agonist" that activates both GLP-1 and GIP receptors. In head-to-head trials, tirzepatide produced slightly more weight loss (20-22% vs 15-17%) and slightly better blood sugar control. Same Novo Nordisk-style retail pricing, similar side effect profile.

So why doesn't everyone just take tirzepatide? Because:

• Less compounded availability. Compounded tirzepatide is harder to source legally because Eli Lilly aggressively pursues compounders.
• Newer drug, less long-term data. Semaglutide has a much larger real-world safety record.
• Insurance coverage is sparser for tirzepatide weight-loss approval (Zepbound).
• Side effect profile is similar but slightly stronger — more nausea early on.

For many patients, semaglutide is the right balance of proven, accessible, and affordable. Tirzepatide is the right call when you want maximum weight loss and have the access path to support it.

Brand-Name vs Compounded: What's the Real Difference?

This is the question every cash-pay patient eventually asks. Let's be clear about what each one is.

Brand-name semaglutide

• FDA-approved through full clinical trials
• Manufactured by Novo Nordisk in centralized facilities
• Identical batch-to-batch quality controls
• Available through pharmacies with insurance coverage or savings cards
• $900-$1,600/month retail

Compounded semaglutide

• Same active ingredient (semaglutide)
• Prepared individually by licensed compounding pharmacies under prescription
• Not FDA-approved — compounded drugs operate under FDA Sections 503A and 503B, which allow individualized preparation
• Quality varies by compounding pharmacy — choose 503B-registered facilities
• Available through telehealth providers without insurance
• $200-$400/month including provider visits

The honest answer: brand-name is the gold standard. Compounded is a legal, accessible alternative when brand-name is unaffordable or unavailable. The FDA has explicitly allowed compounding of semaglutide during the ongoing supply shortage. Choose telehealth providers that disclose their compounding pharmacy and use FDA-registered facilities.

Which One Is Right for You?

Use this quick decision guide:

• Have great insurance with weight-loss coverage? → Wegovy through your insurance is the cheapest path. Talk to your doctor about prior authorization.
• Have type 2 diabetes? → Ozempic is likely covered by insurance. Excellent option.
• Hate needles? → Rybelsus (oral) — but expect slightly less weight loss.
• No insurance / weight-loss exclusion / want to skip the system? → Compounded semaglutide via telehealth. Most affordable cash-pay option.
• Want maximum weight loss and have the budget? → Tirzepatide (Zepbound) if you can access it.

Not sure where you fit? A licensed doctor can evaluate your situation in a 5-minute consultation and recommend the best option.